ロード中...
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
BACKGROUND: Recently, a new coronavirus spreads rapidly throughout the countries and resulted in a worldwide epidemic. Interferons have direct antiviral and immunomodulatory effects. Antiviral effects may include inhibition of viral replication, protein synthesis, virus maturation, or virus release...
保存先:
| 出版年: | Int Immunopharmacol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275997/ https://ncbi.nlm.nih.gov/pubmed/32544867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106688 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|